This page has been robot translated, sorry for typos if any. Original content here.

Attention! The information is for reference only!
Before taking, be sure to consult a doctor!
SITE ONLY DIRECTORY. NOT A PHARMACY! We do not sell medicines! None!

Description of the medicine: Chromolymphotrastum (Chromolymphotrastum)

CHROMOLYMPHOTRAST (Chromolymphotrastum).

The preparation containing dyes: 1, 4-dioxi-5, 8-di (para-toluidino) -anthraquinone and 1-benzoylaminoanthraquinone at 0.0275 g in 100 ml of iodolipol (see).

A thick oil-like liquid of intense green color, transparent in transmitted light, with a peculiar smell.

It is practically insoluble in water, very little in alcohol.

With endolymphatic administration, the drug lingers for a long time in the lymph nodes, staining them in a thick grassy green color, and they become easily distinguishable from the surrounding tissues. Due to the presence of iodolipol in the preparation, it also has radiopaque properties.

Chromolymphotrast is used to control the completeness of the removal of lymph nodes during surgical removal of tumors.

It is administered endolymphatically usually 3 to 7 days before surgery (or earlier); staining of the lymph nodes lasts at least 30 days.

Depending on the nature and location of the tumors, 5 - 10 ml are injected into the corresponding lymphatic vessel (if necessary, 20 ml are introduced into the lymphatic vessels of both limbs). Enter slowly (1 ml for 10 min).

When using the drug, the same side effects are possible as when using iodolipol.

Contraindications: thrombophlebitis and varicose veins of the lower extremities, cardiovascular failure, severe damage to the liver and kidneys, idiosyncrasy to iodine preparations.

Release form: in ampoules of 5 and 10 ml.

Storage: in a dark place at a temperature of at least + 15 C.


In case of precipitation, the ampoule should be heated in hot water (temperature 70 - 80 C) with vigorous shaking for 15 to 20 minutes. The product is suitable for use if the precipitate is completely dissolved.